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ABSTRACT
The clathrin light chains are components of clathrin
coated vesicles, structural constituents Involved in
endocytosls and membrane recycling. The clathrin light
chain B (LCB) gene encodes two isoforms, termed
LCB2 and LCB3, via an alternative RNA splicing
mechanism. We have determined the structure of the
rat clathrin light chain B gene. The gene consists of
six exons that extend over 11.9 kb. The first four exons
and the last exon are common to the LCB2 and LCB3
isoforms. The fifth exon, termed EN, is included in the
mRNA in brain, giving rise to the brain specific form
LCB2 but is excluded in other tissues, generating the
LCB3 isoform. Primary rat neuronal cell cultures
express predominantly the brain specific LCB2 isoform,
whereas primary rat cultures of glia express only the
LCB3 isoform, suggesting that expression of the brain-
specific LCB2 form is limited to neurons. Further
evidence for neuronal localization of the LCB2 form is
provided using a teratocarcinoma cell line, P19, which
can be induced by retinoic acid to express a neuronal
phenotype, concomitant with the induction of the LCB2
form. In order to determine the sequences involved in
alternative splice site selection, we constructed a
minigene containing the alternative spliced exon EN
and its flanking Intron and exon sequences. This
minigene reflects the splicing pattern of the
endogenous gene upon transfection in HeLa cell and
primary neuronal cell cultures, indicating that this
region of the LCB gene contains all the necessary
information for neuron-specific splicing.
INTRODUCTION
Receptor mediated endocytosis occurs by entrapment of specific
macromolecules in coated pits and coated vesicles. Their coat
is predominantly composed of clathrin (1) which is noncovalently
bound to the vesicles. In vitro, it is possible to aggregate clathrin
trimers known as 'triskelions' into closed shell structures. Each
of these trimers consists of three molecules of clathrin heavy chain
and three molecules of clathrin light chain. There is only one
form of clathrin heavy chain, whereas there are two classes of
light chains, light chain A (LCA) and light chain B (LCB). In
addition, the expression of different clathrin light chain isoforms
involves tissue-specific splicing. For LCB there is one
ubiquitously expressed form, LCB3, and a brain-specific form
(LCB2) which has 54 additional nucleotides not found in LCB3
(2-5) . Western blot analysis of various brain parts for LCB2
and immunocytochemical experiments are consistent with the idea
that the LCB2 form is expressed predominantly in neurons (6).
Although the function of the additional exon in brain is not clear,
it has been speculated that it participates in the burst of
endocytosis that mediates membrane recycling after neuronal
stimulation and synaptic vesicle release (1) and might help in
transporting clathrin coated vesicles to the synapse (2).
Alternative splicing is an important mechanism in the
generation of protein isoforms from one gene (7—9). A number
of genes are known to exhibit brain-specific alternative splicing.
Among these genes are the calcitonin/CGRP primary transcript
(10), which leads to the production of calcitonin in thyroid C
cells and calcitonin gene related peptide (CGRP) in the brain.
Other genes studied include the mouse c-src gene (11), the
preprotachykinin gene that produces substance P and K and
related tachykinin peptides (12) and the a-tropomyosin gene (13).
The mechanisms that regulate brain-specific alternative splice site
selection are still poorly understood. However, several cis-
elements that are involved in alternative splice she regulation have
been identified. These elements include sequences within the 5'-
and 3'-splice sites, exon sequences, and sequences located within
introns (11, 12, 14-16). In addition, a brain-specific form of
the Sm B/B' has been reported (17). To date no cellular factors
have been identified that mediate brain-specific alternative splice
patterns.
In this paper we have determined the exon/intron organization
of the clathrin light chain B gene, the first analysis of a clathrin
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light chain gene. We have identified a cell line that provides a
model system to study the alternative splicing of the LCB gene.
In addition, using a transient transfection asssay, we have
determined that the sequences for regulated alternative splicing
are confined to sequences within the neuron-specific exon and
its flanking intron and exon sequences.
MATERIALS AND METHODS
Standard molecular cloning protocols were followed for most of
the experiments (18).
PCR methods and oligonucleotides
PCR reactions were performed in reaction volumes of 50 /d. The
1 x buffer contained 16.6 mM (NH^SO,,, 200/tM dNTPs, 170
/ig/ml bovine serum albumin, 67 mM Tris-HCl, pH 8.8, at 20°C
and the MgCl2 concentration indicated in Table 2. The PCR
reactions were performed using a Gene II (USA Scientific) and
a Perkin Elmer thermocycler. The accuracy of the thermocycler
was tested using an external device (19). The concentration of
the PCR primer was 500 pM for each primer in the final PCR
mix that also contained 1 U Taq DNA polymerase/50 id. Reverse
transcription was carried out using 1 /ig of total RNA, 100 U
of H~ Superscript MMLV reverse transcriptase (BRL), 10 mM
DTT, 1 mM dNTPs, and 50 pmol of the antisense PCR primer.
The sequences of the oligonucleotides are shown in Table 1. All
oligonucleotides were synthesized at the oligonucleotide facility
of the Mount Sinai School of Medicine or the Cold Spring Harbor
Laboratory using an Applied Biosystems Synthesizer.
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Figure 1 A. Intron length in the LCB gene determined by using PCR. DNA from rat genomic X clones was amplified using the oligonucleotide combination indicated.
The sequences of the oligonucleotides are described in Table 1, their location is shown in Figure IB. The reaction conditions for the amplification are described
in Table 2. The identity of the PCR products was confirmed using Southern Blots with intron primers and direct sequencing of flanking regions of the PCR products
using the Maxam-Gilbert method (29). B. Gene structure of the rat clathrin light chain B. The sizes of the introns were determined in a semi-logarithmic plot of
the PCR products from Figure 1A. Oligonucleotides used for sequencing and PCR amplification are indicated as arrows (not to scale), pointing towards the 5' end
of the oligonucleotide. C. Relation between protein structure and intron exon boundaries. The exons are shown as shaded boxes as in Fig. IB. The numbers on
top of the exons are the position of nucleotides in the numbering from Ref. (5). Note that in the numbering from Ref. (5) there is a gap between 657 and 694 that
accounts for the LCA 1 form. The domains of the LCB2 protein are also indicated. Numbers below the protein structure indicate the amino acid position. The numbering
begins with the first methionine of LCB2. The six domains of the LCB2 form are indicated as different boxes, according to Ref. (3).
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Screening and cloning
To obtain genomic clones for the LCB gene we screened 600,000
pfu of a Charon 4A rat genomic library (20) using the ^P end
labeled oligonucleotide JB181. As a probe for hybridization we
used 106 cpm of push column (Stratagene) purified ^P end
labeled JB181 in 5xSSC, 50 mM Na-Phosphate buffer pH 6.8,
1 mM Na4P2O7 and 5xDenhardt's Solution (lxDenhardt :
0.2% Ficoll, 0.2% BSA, and 0.2% polyvinylpyrolidone, M.W.
40,000). The filters were washed with a final stringency of 68°C
in 2 XSSC/0.1 % SDS. This screen resulted in five positive clones,
one of which (X HaeIII-3) contained Exon EH, Em, EIV, EN,
and EV of the LCB gene. This X clone was subcloned into the
plasmid Bluescript SK(+) (Stratagene) using a Kpnl site in intron
C and the EcoRI sites of the Charon 4A polylinker. This resulted
in two subclones, lam-4 and lam-5. Lam-5 contained exon ETV,
EN, EV, and the 3' flanking part of the gene. Lam-4 contained
exon EII and EITJ. The other four X clones obtained contained
only exon EN and EV. To obtain the 5' end of the gene we
screened an EMBL3B library kindly provided by R.Hynes. This
screen was performed using a PCR probe generated with
oligonucleotides SS043 and SS042 (see Figure IB). The probe
was synthesized with 25 /il 800 Ci/mmol dCTP as the only dCTP
present in a 50 /A PCR reaction that contained 100 ng XHaeIII-3
DNA, 200 jtM dATP, dTTP and dGTP each, the lxbuffer
specified above and 1.75 mM MgCl2. The extension time at
72 °C was 4 minutes. We routinely obtain full length probes using
this protocol (21). The probe was purified by precipitation and
heat denatured. 500,000 pfu of the EMBL3B library were probed
in 50% formamide, 50 mM Hepes pH 7.0, lxDenhardt's
solution, 3XSSC, 160 /ig/ml salmon sperm DNA and 20 /ig/ml
yeast tRNA. The filters were washed with a final stringency of
65°C in 0.1 xSSC/0.1 % SDS for one hour. One positive clone
was obtained (XEM3). This clone contained the 5' end of the
gene, exons El to EN and parts of intron E. A Kpnl fragment
of XEM3 that contained exon El was subcloned into Bluescript
Construction of a LCB minigene
A minigene containing the alternatively spliced exon EN and parts
of exons EIV and EV was constructed by amplifying the genomic
region spanned by the oligonucleotides SS030 and SS031 using
1 ng X HaeIII-3 DNA as template. The 4.9 kb fragment could
be amplified by using a four minute extension time. EcoRI linkers
were ligated to the fragment which was subcloned into Bluescript
SK(+). This clone pJS40 was further shortened by removal of
a 800 bp BamHI/Sall fragment in intron E. The truncated insert
was subcloned into the expression vector pQ3 (22) generating
pJS71 (Fig. 5). pfl3 contains the SV40 early promoter and an
SV40 T poly A site.
Cell culture
Standard procedures were used for cell culture and cell
maintenance (23). Primary neuronal cultures of dissociated rat
embryo mesencephalon were cultured in serum free medium as
described (24). P19 embryonal carcinoma (EC) cells were
cultured and induced as described (25,26). HeLa cells and
primary mesencephalic cultures were transfected using lipofectin
(BRL). We plated approximately 800,000 mesencephalic cells
per 35 mm culture dish for each transfection. The cells were
transfected between 3 - 7 days after they were plated. For
transfection, a solution of 10 /xg lipofectin/ml serum free culture
medium was mixed with an equal volume of a solution of 10
/ig/ml DNA in serum free culture medium, giving a final volume
of 1 ml. Both solutions were mixed prior to transfection and added
to the cells. Primary neuronal cultures remained in this medium
for two days. The medium for HeLa cells was changed after an
overnight transfection. RNA was harvested after two days and
prepared using the NP40 lysis method as described (27).
RESULTS
Gene structure of rat clathrin light chain B
Two partially overlapping rat genomic clones, XHaeIII-3 and
XEM3, were obtained from screening a Charon 4A and an
EMBL3B library. These clones were used to determine the gene
structure. The exon/intron structure of the LCB gene was
determined using a PCR approach. Based on the cDNA sequence
(5) we designed oligonucleotides that were complementary to
exon sequences. The sequences of the oligonucleotides are shown
in Table 1. Using the isolated clone DNA as templates, we
determined the size of the introns. The gene structure is shown
in Figure IB. The LCB gene consists of at least six exons that
are separated by five introns of approximately 4, 2.2, 0.4, 1.8,
and 3.1 kb in size. The sequence of the exon/intron boundaries
of the gene were determined using subcloned fragments. The
sequences are shown in Table 3. The exon/intron boundaries were
compared to the consensus sequence for vertebrate splice sites
(7). The 3'-splice site of Exon EIV is unusual as it contains four
consecutive guanosine nucleotides within the polypyrimidine
stretch. Both the 3'- and 5'-splice sites of the alternatively spliced
exon EN are also unusual. The 3'-splice site contains an adenosine
nucleotide prior to the AG. This position is usually occupied by
a pyrimidine nucleotide, mainly a cytosine. The 5'-splice site
contains three nucleotides that differ from the consensus sequence,
two of them are pyrimidine bases instead of purine bases.
Analysis of the alternative splicing patterns of LCB gene in
various cell types
We analyzed several cell lines for the expression of the two
isoforms LCB2 and LCB3. RNA from HeLaS3 (ATCC CCL#
22), AtT20 (ATCC CCL#89) and PC 12 cells (ATCC CRL
Table 1. Oligonucleotides used in this study. Restriction sites in the oUgonucleotides
are underlined.
name
SS0I4
SS030
SS03I
SSO37
SSO4I
SSO42
SSO43
SSO44
SSO45
SSOS1
SSO52
SSO53
SS054
SS056
SSO57
SSO59
SS060
SS061
SS063
JB18I
JB33I
L
21
21
21
17
21
19
20
19
20
20
20
21
21
21
20
19
20
19
19
43
28
sequence 5' — 3'
TCAGGATCCGGCTGCTGCTAG
TGCCTCGAAGGTGAACCGAAC
GGGGTCTCCTCCTTGGATTCT
GATCGCTGACAAAGCGT
TCCCAGAGACTCAAGAGGAAC
TTTTGGCCTTCTCCCGCCC
GGACAGGTTGACTCAGGAGC
TCGCAGCGTAGCCATCGGC
ATGGCTGAGGACTTCGGCTT
GTTCGGAGGACATGGGGACT
CGCTCTCCGACGACGAGAAG
GTGTCCTGGTrTGAGGGCTAT
TTCTGGCTAACGTCCCAGGGT
CrCGCGAGTCCGGGCTGCGCA
AAACACATCTCCATTGACTa
GCAAAGACAGGAGCGTTCT
TTGGCCTGCAGAGAGCAAAG
TTCACCCACCCTGTCCTTC
TGCGCAGCCCGGACTCGCG
TCGAGTGGTATCAGCATCTGGCrGCTGGT-
AGAACGCrTTGTCA
TCGAGTCTTCCGATGCCCTGTTGTTGAT
location
ExooN, antisense
ExonTV, sense
Exon V , antisense
Exon N, sense
Exon V , antisense
Exon IV antisense
Exon I I I sense
Exon I I I , antisense
Exon I, sense
Exon I I , sense
Exon I, antisense
ImronB, sense
IrnronE, sense
Exon I, antisense
Exon II antisense
Intron A , sense
Intron E, antisense
Exon V , sense
Exon I, antisense
Exon EN,
Exon ETV/EV,
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1721) was reverse transcribed and amplified using SS030 and
SS031. We also analyzed RNA from neuroblastoma NB41A3
(ATCC, #CCL 173) and neuro-2a cells (ATCC, #CCL 131)
because these cells are probably derived from the neuronal crest
and might exhibit neuronal properties. Since the light chain B
RNA is not abundantly expressed in most tissues (3) we used
a PCR assay to detect LCB isoforms. RNA from different cell
types was reverse transcribed using the primer SSO31 and PCR
amplified using the primers SSO3O and SSO31 (Table 1). The
primer SSO3O is complementary to sequences in exon EIV, and
SSO31 is complementary to sequences in exon EV. The RNA
from the LCB3 form generated a PCR fragment of 152 bp. The
PCR product generated by LCB2 RNA is 206 bp long, since it
contains the brain-specific exon EN. Both PCR products can be
distinguished by their size and their hybridization patterns. The
PCR product generated by LCB2 RNA hybridizes with the
oligonucleotide JB181 that contains sequences complementary
to exon EN, whereas the PCR product generated by LCB3
hybridizes with the oligonucleotide JB331 that contains sequences
complementary to the flanking parts of exon EIV and EV. From
all cell types examined, only primary neuronal cultures from rat
cortex, mesencephalon or superior cervical ganglion expressed
an amount of LCB2 that was detectable in an ethidium bromide
stained agarose gel (Figure 2). In HeLa, AtT-20, neuroblastoma
NB41A3, neuro-2a, PC 12 and primary glial culture the LCB3
form could be detected using the ethidium bromide stain. If the
PCR products were further analyzed using Southern Blot with
32P end labeled JB181 as a probe, and long exposure time, all
these cells show weak expression of LCB2 (data not shown). This
expression pattern indicates that primary neuronal cultures, like
brain tissue, include the brain specific exon EN in the mRNA
of LCB. It is also worth noting that since the clathrin light chains
A and B are similar and share sequence homology, one might
expect to detect a LCB1 form related to the LCA1 form that
contains a second brain-specific exon (3—5). However, with our
sensitive PCR approach we could not detect a band of the
expected size (241 bp) for a predicted LCB1 form using JB 181
as a probe, which is expected to identify both LCB2 and the
hypothetical LCB1 form.
Induction of the brain specific form of clathrin light chain
B in P19 teratocarcinoma cells
The expression of LCB2 and LCB3 RNA in P19 mouse
teratocarcinoma cells was examined because these cells can be
induced to differentiate into a neuronal phenotype in the presence
of retinoic acid (25). We analyzed the appearance of LCB2 after
different times of retinoic acid treatment. LCB2 mRNA was
detected after four days of retinoic acid treatment (Figure 3). We
found that undifferentiated P19 murine embryonal carcinoma cells
do not contain detectable levels of the brain-specific light chain
Table 2. Reaction conditions for the PCR reactions that were used to determine the intron sizes
in the LCB gene.
#
1
2
3
4
5
6
7
oligonucleotide
SS045/056
SSO63/057
SS051/044
SS042/042
SS030/014
SSO37/O31
SS037/041
MgCl2 cone.
[mM]
3.0
3.5
2.0
3.0
1.5
2.0
3.5
elongation time
[min]
1.5
4.0
3.0
2.0
3.0
4.0
4.0
annealing temp.
[°C]
55
50
57
55
55
55
55
product length
200
4020
2210
370
1790
3143
3250
Table 3. Sequences of the Exon/Irtron boundaries. The sequences were submitted to GenBank, the accession numbers
are L01560-L01565.
Exon Intron
A G G T A A G T consensus
62 77 100 100 60 74 84 50 % usage
g
A
g
A
g
G
G
G
G
t
G
G
G
G
G
T
T
T
T
T
g
A
g
g
A
A
A
A
A
c
G
G
G
G
G
T
c
g
T
T
ExonI— Intron A
Exonll- Intron B
Exonm-Intron C
ExonTV— Intron D
ExonN — Intron E
A. 5' Splice sites in the gene of the clathrin light chain B . The consensus splice site for vertebrates is indicated
(6). Nucleotides that differ from the consensus sequences are indicated by small letters. The numbers indicate the
per cent usage of a particular nucleotide in the consensus sequence.
Intron Exon
P y P y P y P y P y P y P y P y P y P y N C A G G
78 81 83 89 85 82 81 86 91 89 78 100 100 55 % usage
T C C T T g C T C T T T C C A G G T
T G T g C T T T T g T T G t A G G A
T C T g C g g g g C T C A C A G A T
A A C g g T T T T C C T C a A G G A
C T C T C T C T C C T T C A G G G
Intron A — Exonll
Intron B -ExonUI
Intron C-ExonlV
Intron D—ExonN
Intron E—ExonV
B. 3' Splice sites in the gene of the clathrin light chain B.
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LCB2 mRNA. However, upon induction with retinoic acid the
cells express light chain LCB2 mRNA. To further confirm the
correlation between induction of neuronal cell type and LCB2
mRNA expression, cells were induced with DMSO. We were
unable to detect LCB2 mRNA in these cells, consistent with their
muscle eel] phenotype. To test whether LCB2 is simply induced
in response to retinoic acid or as a result of neuronal cell-type
formation, we treated cells in monolayer with retinoic acid. Under
LCB2/LCB3 a r t i f a c t
Figure 2. Distribution of LCB in various cell cultures. 1 fig RNA from the different
cell cultures was reversed transcribed using SS031 and amplified using SSO3O
and SSO31 in 1.5 mM MgClj, 16.6 mM (NItyjSO*, 200*iM dNTPs, 170 /ig/ml
BSA, 67 mM TrisHCl, pH 8.8, at 20°C. 30 cycles were used (1 minute 94°C,
1 minute 55°C, and 2 minutes 72°Q. One tenth of the PCR products was separated
on a 2% agarose gel (TBE). Only primary neuronal cultures express the brain
specific form LCB2 with about the same intensity as brain. As positive controls
plasmids rB2 and rB3 (30) containing cDNA from LCB2 and LCB3 were
amplified, producing the expected bands of 206 and 154 bp length. If the two
plasmids were mixed prior to amplification, a heterodimer PCR artifact probably
consisting of one strand LCB2 and one strand LCB3 appears. This artifact can
also be seen in the PCR products from brain and 1 ° neuronal cell cultures. These
artifacts have also been described for other alternatively spliced genes (31). The
LCB2 and LCB3 form and the artificial heterodimer form are schematically
indicated. The nature of the bands above LCB2 in HeLa cells and below LCB3
in HeLa and primary glial cultures is not known. These bands are probably PCR
artifacts, since they do not hybridize with the internal primers JB181 or JB331
(data not shown). SCG: RNA from superior cervical ganglion, -rev.transcription:
negative control using RNA from primary cultures from mesencephalon without
reverse transcriptase.
these culture conditions EC cells differentiate into fibroblast like
cells with no significant numbers of neuronal cells (25). Here,
we did not observe any LCB2 mRNA induction (Figure 4). This
contrasts with the above experiments where, after four days of
retinoic induction in aggregates, the cells express LCB2 mRNA.
The expression of the LCB2 isoform in P19 teratocarcinoma cells
can be only detected when the PCR products are analyzed using
the sensitive Southern blot method. The induction is barely visible
if the PCR products are stained with ethidium bromide. These
findings demonstrate that the expression of the LCB2 form is
concomitant with the expression of the neuronal phenotype in
the P19 teratocarcinoma cell system, which is also indicated by
the accumulation of LCB2 during the time course of induction.
However, the major form of LCB expressed in the retinoic acid
induced neuron-like P19 teratocarcinoma cells is the peripheral
form LCB3, which is in contrast to the splicing pattern of primary
neuronal cultures. This may indicate differences between the
splicing machinery in neurons and neuron like P19
teratocarcinoma cells.
The expression of a minigene construct in HeLa and primary
neuronal cultures reflects the tissue-specific splicing behavior
of the clathrin light chain B gene
In order to define the necessary cis-acting elements that are
involved in the regulation of the brain specific exon EN, we
constructed a minigene, pJS71, that contained the flanking parts
of exon EIV and EV as well as intron D, exon EN and parts
of intron E (Figure 5). The minigene pJS71 was transfected into
HeLa cells and 1 ° rat mesencephalon cultures. RNA from these
cells was recovered and analyzed by reverse transcription using
SS031 and PCR using the primers SV40A and SS031. The
SV40A primer is complementary to the sequences from the SV40
sequences in pW3. The use of the primer SV40A made it possible
to discriminate between RNA from the transfected construct and
endogenous RNA. The PCR products derived from these
transfection experiments were analyzed in a Southern Blot using
JB181 and JB331 as a probe for LCB2 and LCB3. As shown
in Figure 5, HeLa cells express predominantly the peripheral
form LCB3, whereas primary rat mesencephalon cultures express
predominantly the brain specific form LCB2. These results show
that the minigene has the same cell type specific regulation like
the endogenous gene.
8
i s : : j B
LCB2
LCB3
ICB2
1.CB.1
i tjr
Figure 3. Retinoic acid induction of LCB2 in P19 teratocarcinoma cells. PCR products were separated on 2% SeaKem agarose and transferred to genescreen. A.
Filters were probed with JB 181 which hybridizes to LCB2. B. After being stripped of label .filters were reprobed with JB 331 that detectj LCB3. The autoradiographs
were then superimposed. EC, uninduced cells; DMSO, cells induced for seven days with DMSO; ld,2d,3d,4d, cells induced for one, two, three, and four days
with retinoic acid; RA, cells were induced for four days with retinoic acid and then cultured for three more days in the absence of retinoic acid. MB, mouse brain;
rB2 and rB3, PCR products generated from cloned cDNA templates; 0, negative control of PCR mix without template; 00, negative control using mouse brain
RNA that was not reverse transcribed.
Downloaded from https://academic.oup.com/nar/article-abstract/20/19/5097/2387023
by Cold Spring Harbor Laboratory user
on 08 November 2017
5102 Nucleic Acids Research, Vol. 20, No. 19
A § . . _ B §
1X32
LCB3
LCB2 •
LCB3
LCB gene
p)S71
Figure 4. LCB2 is only expressed in P19 teratocarcinoma cells after neuronal
phenotype formation. A. Filters were probed with JB181 which hybridizes to
LCB2. B. After the label was removed, the filters were reprobed with JB 331
that detects LCB3. The autoradiographs were then superimposed. EC, uninduced
cells; DMSO, cells induced for seven days with DMSO; Ml, EC cells induced
in monolayer with retinoic acid for four days followed by 3 days growth without
retinoic acid; RA, cells were induced for four days with retinoic acid and then
cultured for three more days in the absence of retinoic acid; MB, mouse brain.
DISCUSSION
Gene structure
Protein structure is reflected in the gene structure. The clathrin
light chain proteins can be separated into six domains (3). The
determination of the gene structure reveals that some of these
domains are represented by exons in the LCB gene, as shown
in Figure 1C. The six domains in the LCB protein are: (i) a
phosphorylation site, (ii) a region that is conserved between the
two light chain forms LCA and LCB, (iii) a region that has the
highest variability between LCA and LCB, (iv) a domain that
binds to the heavy chain, (v) a brain specific domain, and (vi)
a C terminal domain (9). Exon El contains the phosphorylation
site, the region that is conserved the most between LCA and LCB
and a part of the region with the highest variability. Exon EH
contains the rest of the region with high variability. The heavy
chain binding domain contains exons EHI and EFV. The brain
specific insert is encoded by exon EN, whose function is yet to
be elucidated, and the carboxy-tenminal domain and the 3'
untranslated region is produced by exon EV.
The 5'- and 3 '-splice sites of the alternative spliced exon EN are
not in consensus. Inspection of the 5'- and 3'-splice sites of the
LCB gene shows that the 5'-splice site of exon EN is divergent
from the vertebrate consensus sequence (Table 3A). This might
be important in the regulation of the alternative splice of exon
EN as it is in the preprotachykinin gene (12). In the case of the
preprotachykinin gene a weak 5'-splice site reduces the ability
of the Ul snRNP to bind to the 5'-splice site thereby limiting
the ability of splicing factors to interact with exon EN. The
3'-splice site of the exon EN also differs from the vertebrate
consensus sequence; the nucleotide prior to the AG nucleotides
is usually a C (Table 3B). Only 2% of all vertebrate genes have
an adenosine residue in this position (7). Thus, the combination
of unusual 5'- and 3'-splice sites might contribute to the exclusion
of exon EN in nonbrain tissue. Why the exon EN is retained
in the mRNA in brain remains to be determined.
Distribution of the splice forms in different cell types
Only primary neuronal cultures reflect the splicing pattern that
is observed in brain. We examined a number of cell cultures to
find a model that mimics the splicing pattern of LCB. From all
cells examined, only primary neuronal cultures from either
1 1
3 i
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1 1
§ § 3 2
in
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4 LCB2 LCB3
Figure 5. Expression of the minigene pJS71 in HeLa cells and primary cultures
from rat mesencephalon. The construction of the minigene pJS71 from the gcnomic
DNA is indicated. The minigene was generated using an SSO3O/SSO31 PCR
fragment in which the BamHI/Sall (B, S) fragment in Intron E was deleted. The
location of the oligonucleotide SV40A in the SV40 promoter (thick arrow) is
indicated. Plasmid DNA of pJS71 was transfected into HeLa cells and primary
rat mesencephalon cultures. The plasmid pJS41 that contained the minigene insert
of pJS71 in the antisense orientation was transfected as a control. The RNA of
the transfected cells was amplified using SV40A and SS031. A. Southern blot
of the PCR products using JB181 as a probe. The brain specific form LCB2 is
expressed in primary rat mesencephalon cultures, not in HeLa cells. B. Reprobing
of the same filter using JB331. The peripheral form LCB3 is expressed
predominantly in HeLa cells, upon longer exposure a band corresponding to LCB3
can can also be seen in primary neuronal cultures.
mesencephalon, cortex or superior cervical ganglion reflected
the splicing pattern found in brain. The finding that primary glial
cultures express only the LCB3 form indicates that the LCB2
form is specific for neurons. Data supporting this theory have
also been found using an antibody that is specific for sequences
encoded in the brain-specific exon (6). The presence of the brain-
specific LCB2 form in cultures from cortex and superior cervical
ganglion indicates that this form is expressed in both the central
and peripheral nervous system. The brain-specific form LCB2
was found to be expressed in P19 teratocarcinoma cells when
these cells are treated with retinoic acid and develop into a
neuronal phenotype. However, when the cells are treated with
retinoic acid under conditions that do not promote the formation
of a neuronal phenotype, no LCB2 form is detectable (Figure 4).
These data further suggest that LCB2 is a neuron-specific isoform.
It is interesting that by contrast immortalized cells that retain
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neuronal properties such as Neuro 2a cells and neuroblastoma
NB41A3 cells mainly express the peripheral form LCB3. Even
in the PI9 system the peripheral form LCB3 is predominant in
cells that have been induced to a neuronal phenotype. A possible
explanation is that immortalized cells could have lost their ability
to include the neuron-specific exon due to their transformation,
indicating that the neuron specific splicing of LCB is only required
when morphological or functional synapses are made. The
interconnection of neurons is a basis for storage and retrieval
of information. This function prohibits further division of neurons
(28). Contrary to neurons, transformed cell lines like Neuro 2a
divide and do not express the neuron specific LCB2 form. Thus,
it may be possible that the neuron specific isoform is necessary
for the communication of neurons that can not take place in
transformed cell lines. The real function of exon N, however,
is not clear.
The information in the splicing cassette of exons ETV to EV
is sufficient for cell specific regulation
In order to define the cis-elements necessary for the brain-specific
alternative splicing and to test whether primary neuronal cultures
can serve as a cellular model in transfection assays, we transfected
a minigene into neuronal and HeLa cells. The splicing pattern
observed in tissue is mimicked by transfection of the minigene
pJS71 in primary neuronal cultures and HeLa cells. Primary
neuronal cultures that contained predominantly neurons and some
glia (24) preferentially included the neuron specific exon EN,
whereas HeLa cells preferentially skipped this exon reflecting
the situation in brain and peripheral tissue. These results indicate
that all the necessary elements for the neuron-specific splice site
selection are located in the alternative spliced exon EN, and its
flanking intron and exon sequences. Furthermore, we
demonstrated that primary neuronal cultures can be used in
analyzing the splicing pattern of minigenes containing brain-
specific exon. Experiments are in progress to further define the
ds-elements involved in neuron-specific splice site selection.
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